1198772-26-7 基本情報 化学名称 linagliptin / metformin CAS No.1198772-26-7 分子式C29H39N13O2 分子601.72 PSA205.85000 LogP2.16920 PubChemID46861711 シノニム 1-carbamimidamido-N,N-dimethylmethanimidamide; Jentadueto; Linagliptin mixture with metformin; すべてを表示 1198772-26-7 性質 ...
Brand Name(s): Tradjenta®, Glyxambi® (as a combination product containing Linagliptin, Empagliflozin), Jentadueto® (as a combination product containing Linagliptin, Metformin), Trijardy® (as a combination product containing Empagliflozin, Linagliptin, Metformin), also available generically Safe...
Linagliptin / metformin Breastfeeding Warnings Safety has not been established Excreted into human milk: Unknown (linagliptin); Yes (metformin) Excreted into animal milk: Yes (linagliptin); Yes (metformin) Comments: -The effects in the nursing infant or the effects on milk production are unknown....
Generic name:linagliptin and metformin [LIN-a-GLIP-tin-and-met-FOR-min] Brand names:Jentadueto,Jentadueto XR Dosage forms:oral tablet (2.5 mg-1000 mg; 2.5 mg-500 mg; 2.5 mg-850 mg), oral tablet, extended release (2.5 mg-1000 mg; 5 mg-1000 mg) ...
are allergic to linagliptin, metformin, or any of the ingredients in JENTADUETO Symptoms of an allergic reaction may include rash, itching, flaking or peeling of your skin; raised red patches on your skin (hives); and swelling of your face, lips, tongue and throat that may cause difficulty ...
详细解释: 治疗II型糖尿病药物西他列汀(Sitagliptin),2006年10月17由FDA批准,是Merck生产的商品药Januvia的有效成分,而西他列汀(Sitagliptin)和甲福明二甲双胍(Metformin)的混合口服药用商品名Janumet。西他列汀是DPP-4 (dipeptidyl peptidase 4)的酶抑制剂,与Linagliptin(利拉利汀)有相同的作用机制。
MetforminPioglitazoneGlycaemic ControlSulfonylureaSitagliptinLinagliptin (Trajenta, Tradjenta, Trazenta, Trayenta) is an oral, highly selective inhibitor of dipeptidyl peptidase-4 and is the first agent of its class to be eliminated predominantly via a nonrenal route. Linagliptin is indicated for once-...
are allergic to linagliptin (TRADJENTA), metformin, or any of the ingredients in JENTADUETO or JENTADUETO XR. Symptoms of an allergic reaction may include rash, itching, flaking, or peeling; raised red patches on your skin (hives); and swelling of your face, lips, tongue, and throat that ...
Taskinen MR, Rosenstock J, Tamminen I, et al. Safety and efficacy of linagliptin as add-on therapy to metformin in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled study. Diabetes Obes Metab. 2011;13(1):65-74. ...
药品名称 利格列汀+二甲双胍; linagliptin+metformin; Jentadueto; Trajenta Duo; 欧双宁; DW6013 单方药品 二甲双胍 利格列汀 药品类别 创新药; 化药; 复方; 小分子 靶点 dipeptidyl peptidase-4 (DPP-4); gamma-secretase subunit PEN-2 作用机制 双胍类降糖药; DPP-4抑制剂 药品简介 --...